Drug:
Reaction: WEIGHT DECREASED
20250101 - 20251231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 25098937 |
CA |
2 | |
Pulmonary fibrosis, Wheezing, Stomatitis, Psoriatic arthropathy, Weight increased, Synovitis, Peripheral swelling, Rheumatoid arthritis, Pericarditis, Systemic lupus erythematosus, Weight decreased, Rash vesicular, Swelling, Wound, Pneumonia, Psoriasis, Sleep disorder due to general medical condition, insomnia type, Urticaria, Pyrexia, Wound infection, Rash, X-ray abnormal, Rheumatic fever, Sinusitis, Vomiting, Subcutaneous drug absorption impaired, Type 2 diabetes mellitus, Sleep disorder, Pemphigus, Pruritus, Rheumatoid factor positive, Swollen joint count increased, Pustular psoriasis, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SULFASALAZINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, OXYCODONE, LISINOPRIL, DESOGESTREL AND ETHINYL ESTRADIOL, CALCIUM GLUCONATE, LANSOPRAZOLE, LORAZEPAM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, QUETIAPINE FUMARATE, QUETIAPINE, OXYCODONE HYDROCHLORIDE, OXYCODONE, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, DICLOFENAC, DICLOFENAC SODIUM, SECUKINUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ADALIMUMAB-ADAZ, RAMIPRIL, |
||||
| 302 | 25099006 |
CA |
||
Weight decreased, Pancreatitis, Cholelithiasis, Gastroenteritis viral, Condition aggravated, Headache, Back pain, Constipation, Abdominal pain upper, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, PREDNISONE, |
||||
| 303 | 25099144 |
US |
2 | |
Surgery, Productive cough, Dry throat, Social problem, Disturbance in attention, Weight decreased, Tremor, |
||||
CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, |
||||
| 304 | 25099231 |
US |
||
Weight decreased, Arthralgia, |
||||
ISOTRETINOIN, |
||||
| 305 | 25099291 |
US |
61 | 2 |
Haemoptysis, Hypertension, Headache, Dehydration, Abdominal pain, Fatigue, Weight increased, Arthralgia, Palmar-plantar erythrodysaesthesia syndrome, Dry skin, Stomatitis, Urticaria, Vomiting, Nausea, Diarrhoea, Dysphonia, Hyperacusis, Tinnitus, Weight decreased, |
||||
LENVATINIB, LENVATINIB, |
||||
| 306 | 25099704 |
US |
72 | 1 |
Weight decreased, Blood glucose increased, Glycosylated haemoglobin increased, Drug ineffective, Inappropriate schedule of product administration, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ORAL SEMAGLUTIDE, |
||||
| 307 | 25099779 |
US |
72 | 2 |
Weight decreased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 308 | 25099882 |
BR |
52 | 2 |
Metastases to bone, Spinal deformity, Decreased immune responsiveness, Lip dry, Dry throat, Sluggishness, Throat clearing, Vulvovaginal dryness, Visual impairment, Concomitant disease aggravated, Atrophy, Gait inability, Illness, Intervertebral disc protrusion, Dry skin, Platelet count decreased, Nausea, Cough, Nausea, Asthenia, Eating disorder, Weight increased, Muscle spasms, Hypoaesthesia, Limb discomfort, Insomnia, Adverse drug reaction, Anxiety, Decreased appetite, Weight decreased, Decreased immune responsiveness, Fear, Pain in extremity, Bone pain, Vomiting, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, ANASTROZOLE, ANASTROZOLE TABLETS, |
||||
| 309 | 25100025 |
83 | 1 | |
Pneumonia aspiration, Urinary tract infection pseudomonal, Acute kidney injury, Hypotension, Weight decreased, Respiratory failure, Staphylococcus test positive, |
||||
PEMBROLIZUMAB, |
||||
| 310 | 25100028 |
US |
61 | 1 |
Neuropathy peripheral, Neuropathic arthropathy, Left ventricular failure, Gastric bypass, Tumour marker increased, Ulcer haemorrhage, Weight decreased, |
||||
BOSUTINIB, |
||||
| 311 | 25100247 |
US |
85 | 2 |
Weight decreased, Diarrhoea, |
||||
POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350, |
||||
| 312 | 25100262 |
US |
62 | 1 |
Sarcopenia, Cardiac arrest, Chest pain, Dyspnoea, Troponin increased, Acute myocardial infarction, Ischaemic hepatitis, Deep vein thrombosis, Pulmonary embolism, Haemothorax, Fatigue, Weight decreased, Type 2 diabetes mellitus, Hypertension, |
||||
BUDESONIDE, BUDESONIDE, ERGOCALCIFEROL, CARVEDILOL, PREDNISONE, SIMVASTATIN, SPIRONOLACTONE, SPIRONOLACTONE, AMLODIPINE, APIXABAN, |
||||
| 313 | 25100296 |
CA |
1 | |
Weight decreased, Blood urine present, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 314 | 25100422 |
US |
68 | 1 |
Nausea, Weight decreased, Off label use, |
||||
RIFABUTIN, RIFABUTIN, |
||||
| 315 | 25100487 |
51 | 2 | |
Lupus-like syndrome, Synovitis, Arthralgia, Myalgia, Weight decreased, Fatigue, Rhinalgia, White blood cell count decreased, |
||||
MESALAMINE, THYROID, PORCINE, |
||||
| 316 | 25100497 |
AU |
42 | |
Gastrointestinal microorganism overgrowth, Gastrointestinal pain, Disaccharidase deficiency, Weight decreased, Abdominal distension, Diarrhoea, |
||||
ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, PANCRELIPASE, |
||||
| 317 | 25100502 |
US |
2 | |
Decreased appetite, Weight decreased, |
||||
OLANZAPINE AND SAMIDORPHAN L-MALATE, |
||||
| 318 | 25100512 |
US |
||
Weight decreased, |
||||
C1 ESTERASE INHIBITOR RECOMBINANT, |
||||
| 319 | 25100532 |
IT |
2 | |
Death, Neoplasm recurrence, Malignant neoplasm progression, Pain, Medication error, Weight decreased, |
||||
GEMCITABINE HYDROCHLORIDE, DURVALUMAB, TREMELIMUMAB, CARBOPLATIN, |
||||
| 320 | 25100561 |
US |
85 | 2 |
Hospitalisation, Weight decreased, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ARTIFICIAL TEARS, LUBRICANT EYE DROPS, POLYVINYL ALCOHOL, POVIDONE, GLYCERIN, ASCORBIC ACID, CALCIUM, SERTACONAZOLE NITRATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OMALIZUMAB, FUROSEMIDE, IPRATROPIUM BROMIDE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE PROPIONATE, AZELASTINE HYDROCHLORIDE, AZELASTINE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, ROSUVASTATIN CALCIUM, CEPHALEXIN, FERROUS SULFATE, TIOTROPIUM BROMIDE, SEMAGLUTIDE, PREDNISONE, ACYCLOVIR, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, GLIPIZIDE, |
||||
| 321 | 25100593 |
US |
71 | 2 |
Dehydration, Cholecystitis, Fluid intake reduced, Decreased appetite, Weight decreased, Malignant neoplasm progression, |
||||
LENVATINIB, LENVATINIB, |
||||
| 322 | 25100654 |
US |
1 | |
Decreased appetite, Weight decreased, |
||||
OLANZAPINE AND SAMIDORPHAN L-MALATE, |
||||
| 323 | 25100682 |
CA |
22 | 1 |
Crohn^s disease, Drug ineffective, Gastroenteritis viral, Feeling cold, Asthenia, Gait disturbance, Gastrointestinal inflammation, Muscle atrophy, Musculoskeletal stiffness, Off label use, Sitting disability, Weight decreased, |
||||
INFLIXIMAB, VEDOLIZUMAB, VEDOLIZUMAB, METHOTREXATE, METHOTREXATE SODIUM, UPADACITINIB, |
||||
| 324 | 25100742 |
US |
69 | 1 |
Hallucination, Hallucination, visual, Delusional perception, Paranoia, Weight decreased, Dyskinesia, Condition aggravated, Agitation, Confusional state, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, |
||||
| 325 | 25101204 |
CA |
2 | |
Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthritis, Arthropathy, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Bone erosion, Breast cancer stage III, Bronchitis, C-reactive protein increased, Chest pain, Condition aggravated, Confusional state, Contusion, Crohn^s disease, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Disability, Discomfort, Dislocation of vertebra, Dizziness, Drug-induced liver injury, Duodenal ulcer perforation, Dyspepsia, Ear infection, Exostosis, Fatigue, Fibromyalgia, Folliculitis, Foot deformity, Gait disturbance, Gait inability, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic cirrhosis, Hepatic enzyme increased, Hip arthroplasty, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Infection, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint stiffness, Joint swelling, Laryngitis, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower limb fracture, Lupus vulgaris, Lupus-like syndrome, Memory impairment, Mobility decreased, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Oedema, Oedema peripheral, Osteoarthritis, Osteoporosis, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Prescribed overdose, Prescribed underdose, Pruritus, Psoriasis, Psoriatic arthropathy, Pyrexia, Pulmonary fibrosis, Rash, Red blood cell sedimentation rate increased, Retinitis, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Seronegative arthritis, Sciatica, Sinusitis, Sleep disorder, Sleep disorder due to a general medical condition, Spinal fusion surgery, Spondylitis, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Tachycardia, Systemic lupus erythematosus, Type 2 diabetes mellitus, Upper respiratory tract infection, Urticaria, Visual impairment, Vomiting, Walking aid user, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, Dyspnoea, |
||||
ETANERCEPT, ETANERCEPT, APREMILAST, APREMILAST, APREMILAST, APREMILAST, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALENDRONATE SODIUM, AZATHIOPRINE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE ACETATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CLONIDINE HYDROCHLORIDE, CLONIDINE, HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, MESALAMINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, PREGABALIN, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, SODIUM FLUORIDE, SODIUM FLUORIDE F 18, SODIUM FLUORIDE F-18, TOOTHPASTE, SODIUM FLUORIDE F18, CLEAR MINT, GEL TOOTHPASTE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRICLOSAN, USTEKINUMAB, ERGOCALCIFEROL, |
||||
| 326 | 25101600 |
US |
72 | 2 |
Cholecystectomy, Nerve compression, Illness, Hypotension, Hypertension, Muscle spasms, Dizziness, Weight decreased, |
||||
CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN C, FERROUS SULFATE, PSYLLIUM HUSK, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ARMODAFINIL, |
||||
| 327 | 25101662 |
US |
73 | 2 |
Pneumonia, Influenza, Weight decreased, Diarrhoea, |
||||
LENALIDOMIDE, IXAZOMIB, |
||||
| 328 | 25101696 |
US |
65 | 2 |
Product tampering, Weight decreased, Dry mouth, Nausea, Dyspepsia, Vomiting, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 329 | 25101835 |
FR |
75 | 1 |
Arthralgia, Nausea, Fatigue, Weight decreased, Depression, Off label use, |
||||
LUSPATERCEPT, |
||||
| 330 | 25101899 |
US |
||
Systemic lupus erythematosus, Weight decreased, Contusion, Loss of personal independence in daily activities, |
||||
BELIMUMAB, |
||||
| 331 | 25102012 |
CO |
58 | 2 |
Decreased immune responsiveness, Hepatitis, Decreased immune responsiveness, White blood cell count abnormal, Haemoglobin abnormal, Platelet count increased, Cystitis, Gastritis, Weight decreased, Inflammation, Pain, Dyspnoea, Urinary tract infection, Drug intolerance, Off label use, |
||||
FULVESTRANT, FULVESTRANT, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, LEVOTHYROXINE, |
||||
| 332 | 25102075 |
US |
61 | 2 |
Diabetes mellitus, Weight decreased, Diarrhoea, |
||||
PEMBROLIZUMAB, |
||||
| 333 | 25102111 |
US |
49 | 2 |
Hypothyroidism, Colitis, Adrenal insufficiency, Ocular toxicity, Hypertransaminasaemia, Otitis externa, Ulcer, Weight decreased, Off label use, Ocular toxicity, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, LENVATINIB, LENVATINIB, LENVATINIB, LENVATINIB, LENVATINIB, LENVATINIB, LENVATINIB, LENVATINIB, |
||||
| 334 | 25102121 |
US |
55 | 1 |
Weight decreased, |
||||
TRAMETINIB, |
||||
| 335 | 25102224 |
FR |
50 | 1 |
Blood glucose increased, Blood glucose increased, Decreased appetite, Weight decreased, Fall, Malaise, |
||||
DULAGLUTIDE, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 336 | 25102382 |
IL |
75 | 1 |
Lung neoplasm malignant, Stress, Dysphagia, Weight decreased, Hypocalcaemia, On and off phenomenon, Dyspnoea, Pulmonary imaging procedure abnormal, Dyspnoea, |
||||
| 337 | 25102400 |
CA |
44 | 2 |
Injury, Maternal exposure during pregnancy, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Porphyria acute, Pruritus, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Rectal haemorrhage, Retinitis, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sinusitis, Sciatica, Sleep disorder due to a general medical condition, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Visual impairment, Vomiting, Weight decreased, Weight fluctuation, Weight increased, Wheezing, White blood cell count increased, Wound, Wound infection, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, SECUKINUMAB, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FLUOROMETHOLONE, LEFLUNOMIDE, MAGNESIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREGABALIN, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, RITUXIMAB, RITUXIMAB, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LORAZEPAM, CAFFEINE, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, ERYTHROMYCIN, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYALURONIDASE, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LANSOPRAZOLE, LISINOPRIL, LORAZEPAM, MELOXICAM, MESALAMINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MORPHINE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, APREMILAST, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LANSOPRAZOLE, RAMIPRIL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, SULFASALAZINE, SULFASALAZINE, ALBUTEROL SULFATE, ALBUTEROL, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB, TOFACITINIB, LISINOPRIL, SECUKINUMAB, |
||||
| 338 | 25104358 |
70 | 2 | |
Arthralgia, Weight decreased, Malaise, |
||||
CABOTEGRAVIR AND RILPIVIRINE, |
||||
| 339 | 25092106 |
CA |
2 | 1 |
Pneumatosis intestinalis, Failure to thrive, Weight decreased, Stomatitis, Hypogammaglobulinaemia, Escherichia bacteraemia, Gastrointestinal disorder, Hypophagia, CD19 lymphocytes decreased, Norovirus infection, Diarrhoea, |
||||
BLINATUMOMAB, |
||||
| 340 | 25092115 |
CO |
67 | 2 |
Cerebrovascular accident, Weight decreased, Back pain, |
||||
SECUKINUMAB, BUPRENORPHINE, WARFARIN, |
||||
| 341 | 25092124 |
CA |
||
Diabetes mellitus inadequate control, Frequent bowel movements, Weight decreased, |
||||
VEDOLIZUMAB, |
||||
| 342 | 25092191 |
FI |
||
Oral pain, General physical health deterioration, Cutaneous symptom, Weight decreased, Insomnia, |
||||
ADALIMUMAB, |
||||
| 343 | 25092208 |
CA |
2 | |
Pulmonary fibrosis, Wound infection, Pustular psoriasis, Weight increased, Pericarditis, Type 2 diabetes mellitus, Peripheral swelling, Systemic lupus erythematosus, Rash vesicular, Sleep disorder, Rheumatoid arthritis, Synovitis, Pruritus, Swollen joint count increased, Rheumatic fever, Psoriasis, Rash, Subcutaneous drug absorption impaired, Weight decreased, Wheezing, Pneumonia, Swelling, X-ray abnormal, Pemphigus, Sleep disorder due to general medical condition, insomnia type, Pyrexia, Sinusitis, Rheumatoid factor positive, Urticaria, Stomatitis, Wound, Psoriatic arthropathy, Vomiting, |
||||
DICLOFENAC SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LANSOPRAZOLE, CALCIUM GLUCONATE, SULFASALAZINE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LISINOPRIL, LORAZEPAM, SECUKINUMAB, RAMIPRIL, OXYCODONE, ADALIMUMAB-ADAZ, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DESOGESTREL AND ETHINYL ESTRADIOL, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, QUETIAPINE FUMARATE, QUETIAPINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 344 | 25092321 |
US |
12 | 1 |
Gallbladder rupture, Weight decreased, |
||||
TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, |
||||
| 345 | 25092323 |
US |
70 | 2 |
Pulmonary cavitation, Condition aggravated, Weight decreased, Fatigue, |
||||
AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, RIFAMPIN, RIFAMPIN, AMIKACIN, |
||||
| 346 | 25092493 |
US |
62 | 2 |
Weight decreased, |
||||
AGALSIDASE BETA, |
||||
| 347 | 25092580 |
US |
52 | 2 |
Dizziness, Fall, Weight decreased, Drug tolerance decreased, |
||||
TREPROSTINIL, TREPROSTINIL, FUROSEMIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, SILDENAFIL CITRATE, SILDENAFIL, MACITENTAN, MONTELUKAST SODIUM, MONTELUKAST, OXYGEN, 0XYGEN, HYDROCHLOROTHIAZIDE, LORATADINE, LORATADINE ORAL, |
||||
| 348 | 25092583 |
US |
1 | |
Product dose omission issue, Skin disorder, Malaise, Alopecia, Skin atrophy, Pruritus, Weight decreased, Dry skin, Joint swelling, Rash, Exercise tolerance decreased, |
||||
RIVAROXABAN, |
||||
| 349 | 25092743 |
PL |
77 | 1 |
Gastric ulcer, Weight decreased, Decreased appetite, |
||||
DARATUMUMAB, LENALIDOMIDE, LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 350 | 25092873 |
US |
1 | |
Weight decreased, Blood pressure decreased, Asthenia, Device information output issue, |
||||
TREPROSTINIL, TREPROSTINIL, TAMSULOSIN HYDROCHLORIDE, ATORVASTATIN CALCIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE, AZELASTINE HYDROCHLORIDE, AZELASTINE, IBUPROFEN, NINTEDANIB, LANSOPRAZOLE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ONDANSETRON HYDROCHLORIDE, |
||||
| 351 | 25092957 |
FR |
48 | 2 |
Constipation, Vomiting, Weight decreased, Infection, Therapy interrupted, Therapy non-responder, |
||||
PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, PEMBROLIZUMAB, PEMBROLIZUMAB, CISPLATIN, METHYLPREDNISOLONE, |
||||
| 352 | 25093188 |
CA |
2 | |
Liver injury, General symptom, Headache, General physical health deterioration, Infection, Hypoaesthesia, Ill-defined disorder, Hypertension, Helicobacter infection, Hypersensitivity, Hypercholesterolaemia, Impaired healing, Hand deformity, Injury, Glossodynia, Grip strength decreased, Infusion related reaction, Hepatic enzyme increased, Sinusitis, Urticaria, Sleep disorder due to general medical condition, insomnia type, Adjustment disorder with depressed mood, Pemphigus, Wheezing, Psoriatic arthropathy, Joint range of motion decreased, Abdominal pain upper, Subcutaneous drug absorption impaired, Contusion, Psoriasis, Myositis, Pneumonia, Pain in extremity, Systemic lupus erythematosus, Pulmonary fibrosis, Vomiting, Blister, Wound infection, Swelling, Oedema, Rash, Chest pain, Lower respiratory tract infection, Amnesia, Migraine, Back disorder, Pruritus, Stomatitis, Memory impairment, Mobility decreased, Decreased appetite, Rheumatic fever, Muscle injury, X-ray abnormal, Weight increased, Swollen joint count increased, Sleep disorder, Type 2 diabetes mellitus, Synovitis, Breast cancer stage II, Wound, Weight decreased, Malaise, Rheumatoid arthritis, Joint swelling, Irritable bowel syndrome, Rash vesicular, Peripheral swelling, Pericarditis, Pustular psoriasis, Pyrexia, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ETANERCEPT, ETANERCEPT, ETANERCEPT, USTEKINUMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, CAFFEINE CITRATE, CAFFEINE CITRATE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, NAPROXEN, NAPROXEN SODIUM, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, CALCIUM GLUCONATE, ALENDRONATE SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, RAMIPRIL, PHENYLEPHRINE HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, LEFLUNOMIDE, LEFLUNOMIDE, LISINOPRIL, LISINOPRIL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SARILUMAB, SARILUMAB, QUETIAPINE FUMARATE, QUETIAPINE, VEDOLIZUMAB, VEDOLIZUMAB, LORAZEPAM, LORAZEPAM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, PREDNISONE, SECUKINUMAB, SECUKINUMAB, CALCIUM CARBONATE, INFLIXIMAB, INFLIXIMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, LANSOPRAZOLE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, VITAMIN C, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ACETAMINOPHEN AND CAFFEINE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, CERTOLIZUMAB PEGOL, ADALIMUMAB, ADALIMUMAB, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERGOCALCIFEROL, ERGOCALCIFEROL, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 353 | 25093373 |
US |
79 | |
Hunger, Nervousness, Weight decreased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 354 | 25093705 |
NL |
32 | 1 |
Illness, Dyspnoea, Weight decreased, Pyrexia, |
||||
PALIVIZUMAB, PALIVIZUMAB, PALIVIZUMAB, |
||||
| 355 | 25093735 |
US |
78 | 2 |
Fear of injection, Gastrointestinal disorder, Weight decreased, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, POLYETHYLENE GLYCOL 3350, MAGNESIUM HYDROXIDE, ASPIRIN, CITRIC ACID, SODIUM BICARBONATE EFFERVESCENT TABLET, BUFFERED ASPIRIN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 356 | 25093766 |
US |
1 | |
Loss of personal independence in daily activities, Weight decreased, Dyspnoea exertional, |
||||
DUPILUMAB, SEMAGLUTIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL TARTRATE, METOPROLOL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, |
||||
| 357 | 25093782 |
US |
34 | 1 |
Weight decreased, Injection site swelling, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 358 | 25093958 |
US |
58 | 2 |
Chills, Dyspnoea, Infection, Weight decreased, Off label use, |
||||
NINTEDANIB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 359 | 25093961 |
GB |
78 | 1 |
Vomiting, Weight decreased, Haemoglobin decreased, |
||||
LANREOTIDE ACETATE, |
||||
| 360 | 25093972 |
CA |
70 | 1 |
Systemic lupus erythematosus, Weight decreased, Insomnia, Decreased appetite, Gastroenteritis viral, Nausea, Feeling abnormal, Poor quality sleep, |
||||
NINTEDANIB, NINTEDANIB, |
||||
| 361 | 25094138 |
CA |
97 | 2 |
Abdominal pain upper, Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Back disorder, Blister, Blood cholesterol increased, Breast cancer stage II, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Duodenal ulcer perforation, Dyspepsia, Fatigue, Fluid retention, Fibromyalgia, Folliculitis, Gait disturbance, Gastrointestinal disorder, Gait inability, General physical health deterioration, General symptom, Grip strength decreased, Glossodynia, Hand deformity, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Liver injury, Lower respiratory tract infection, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Myositis, Nasopharyngitis, Nausea, Oedema, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriatic arthropathy, Psoriasis, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Rheumatoid factor positive, Rheumatoid arthritis, Sleep disorder, Sinusitis, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Type 2 diabetes mellitus, Systemic lupus erythematosus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, X-ray abnormal, Wound infection, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM CARBONATE, ANTACID, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, IODINE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE HYDROCHLORIDE, OXYCODONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, VITAMIN C, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, CALCIUM, ERGOCALCIFEROL, LANSOPRAZOLE, LISINOPRIL, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, SULFASALAZINE, SULFASALAZINE, FISH OIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, LORAZEPAM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 362 | 25094197 |
AT |
2 | |
Pneumococcal sepsis, Chronic graft versus host disease oral, Chronic graft versus host disease in liver, Scleroderma-like reaction, Scleroderma, Dry eye, Disease progression, Infection, Rash maculo-papular, Infection, Dyspnoea, Dysphagia, Weight decreased, |
||||
CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, ABACAVIR SULFATE, ABACAVIR, LAMIVUDINE, LAMIVUDINE ORAL, RUXOLITINIB, |
||||
| 363 | 25094318 |
US |
||
Blood pressure increased, Weight decreased, Incorrect dose administered, |
||||
RELUGOLIX, |
||||
| 364 | 25094374 |
US |
2 | |
Weight decreased, Hypotension, |
||||
RIOCIGUAT, RIOCIGUAT, RIOCIGUAT, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, TERBINAFINE HYDROCHLORIDE, TERBINAFINE TABLETS 250 MG, TERBINAFINE HYDROCHLORIDE 1G IN 100G, PANTOPRAZOLE SODIUM, APIXABAN, DESVENLAFAXINE, DESVENLAFAXINE SUCCINATE, |
||||
| 365 | 25094442 |
CA |
||
Hypertension, Therapeutic response shortened, Feeling abnormal, Bacterial food poisoning, Malaise, Tongue pruritus, Chest discomfort, Alopecia, Fatigue, Blood pressure increased, Insomnia, Weight decreased, Condition aggravated, Inappropriate schedule of product administration, Off label use, Off label use, Intentional product use issue, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 366 | 25094560 |
US |
58 | 2 |
Alopecia, Weight decreased, Feeling abnormal, Gastric infection, Malaise, Diarrhoea, Vomiting, Dehydration, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 367 | 25094810 |
US |
47 | 1 |
Feeling abnormal, Sleep disorder due to general medical condition, insomnia type, Weight decreased, Abdominal distension, Flatulence, Eructation, Vomiting, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 368 | 25094867 |
CA |
||
Behaviour disorder, Decreased appetite, Drooling, Dysarthria, Fatigue, Gait disturbance, Hyperammonaemic encephalopathy, Lethargy, Seizure, Sleep disorder, Somnolence, Tremor, Weight decreased, |
||||
STIRIPENTOL, CLOBAZAM, |
||||
| 369 | 25094922 |
BR |
||
Weight decreased, Product tampering, |
||||
TIRZEPATIDE, |
||||
| 370 | 25095373 |
PK |
38 | 2 |
Weight decreased, Weight increased, Off label use, |
||||
TRASTUZUMAB-QYYP, TRASTUZUMAB-QYYP, TRASTUZUMAB-QYYP, |
||||
| 371 | 25095540 |
HU |
||
Neuropathy peripheral, Pain, Decreased appetite, Weight decreased, Malaise, |
||||
ADO-TRASTUZUMAB EMTANSINE, GABAPENTIN, |
||||
| 372 | 25095903 |
US |
||
Porphyria acute, Weight decreased, Blood glucose fluctuation, |
||||
GIVOSIRAN SODIUM, GIVOSIRAN SODIUM, |
||||
| 373 | 25096111 |
PT |
76 | 1 |
Neuropathy peripheral, Neutropenia, Acute kidney injury, Respiratory failure, Cardiac failure, Rectal haemorrhage, Haemorrhoidal haemorrhage, Atrial fibrillation, Hyperglycaemia, Dry skin, Skin exfoliation, Erythema, Decreased appetite, Weight decreased, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, APIXABAN, BISOPROLOL FUMARATE, ROSUVASTATIN, |
||||
| 374 | 25096174 |
US |
2 | |
Weight decreased, Decreased appetite, |
||||
RISANKIZUMAB-RZAA, |
||||
| 375 | 25096393 |
US |
61 | 2 |
Weight decreased, Norovirus infection, Influenza, Illness, |
||||
TOFACITINIB, HYDROXYCHLOROQUINE SULFATE, |
||||
| 376 | 25096394 |
US |
59 | 1 |
Fatigue, Decreased appetite, Weight decreased, |
||||
AXITINIB, |
||||
| 377 | 25096710 |
US |
||
Hospitalisation, Weight decreased, |
||||
GIVOSIRAN SODIUM, |
||||
| 378 | 25096735 |
US |
79 | 1 |
Weight decreased, |
||||
LENALIDOMIDE, |
||||
| 379 | 25097164 |
BE |
72 | 1 |
Gastrointestinal disorder, Feeding disorder, Dystonia, Oesophagitis, Weight decreased, Abdominal pain upper, Nausea, Vomiting, Appetite disorder, Hyperchlorhydria, Fall, Enteral nutrition, C-reactive protein increased, Dyskinesia, Salivary hypersecretion, Pneumonia aspiration, Gait inability, Aphasia, Speech disorder, On and off phenomenon, Muscle rigidity, |
||||
CARBIDOPA, LEVODOPA, AND ENTACAPONE, SAFINAMIDE MESYLATE, AMITRIPTYLINE HYDROCHLORIDE, DESLORATADINE, |
||||
| 380 | 25099829 |
38 | 2 | |
Abdominal discomfort, Weight decreased, |
||||
APREMILAST, |
||||
| 381 | 25086819 |
US |
2 | |
Pneumonia, Back pain, Weight decreased, Headache, Brain fog, Respiratory symptom, Cough, Sinusitis, Rhinorrhoea, Decreased immune responsiveness, |
||||
OFATUMUMAB, OFATUMUMAB, |
||||
| 382 | 25086971 |
US |
78 | |
Hot flush, Hypogeusia, Weight decreased, |
||||
APIXABAN, |
||||
| 383 | 25086993 |
DE |
2 | |
Neoplasm malignant, Condition aggravated, Weight decreased, Asthenia, Constipation, Nausea, Diarrhoea, |
||||
SEMAGLUTIDE, |
||||
| 384 | 25087030 |
US |
73 | 2 |
Pneumonia, White blood cell count decreased, Feeling abnormal, Pallor, Motion sickness, Haemoglobin decreased, Fatigue, Headache, Eye disorder, Weight decreased, Influenza, Product packaging difficult to open, Product use issue, Diarrhoea, |
||||
IXAZOMIB, LENALIDOMIDE, ACYCLOVIR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DIPHENHYDRAMINE HYDROCHLORIDE, OIL, BIOTIN, HAIR, LISINOPRIL, IBUPROFEN, ERGOCALCIFEROL, |
||||
| 385 | 25087041 |
US |
||
Seizure, Decreased immune responsiveness, Surgery, Meningioma, Tumour excision, Craniotomy, Pharyngeal swelling, Joint swelling, Irritability, Insomnia, Fluid retention, Flatulence, Nail infection, Fatigue, Gait disturbance, Amnesia, Disturbance in attention, Anxiety, Coordination abnormal, Hypoaesthesia, Visual impairment, Scar, COVID-19, Diplopia, Weight decreased, Peripheral swelling, Blood pressure decreased, Wrong technique in product usage process, Product size issue, Product availability issue, Adverse drug reaction, Off label use, |
||||
LEVETIRACETAM, LEVETIRACETAM, LEVETIRACETAM, |
||||
| 386 | 25087105 |
US |
2 | |
Thrombosis, Cataract, Confusional state, Respiratory tract congestion, Weight decreased, Cough, Productive cough, Headache, Back pain, Pain in extremity, Somnolence, Wrong technique in product usage process, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, NIFEDIPINE, RIVAROXABAN, RIVAROXABAN, SILDENAFIL CITRATE, SILDENAFIL, IRON, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, TIZANIDINE HYDROCHLORIDE, ERGOCALCIFEROL, AMBRISENTAN, CLOPIDOGREL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LOSARTAN POTASSIUM, LOSARTAN, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, SELEXIPAG, |
||||
| 387 | 25087114 |
US |
2 | |
Seizure, Hypersensitivity, Hypersomnia, Product dose omission issue, Weight decreased, Decreased appetite, |
||||
TROFINETIDE, |
||||
| 388 | 25087153 |
US |
1 | |
Weight decreased, |
||||
APIXABAN, |
||||
| 389 | 25087266 |
CA |
44 | 2 |
Breast cancer stage III, Depression, Therapy non-responder, Vomiting, Hand deformity, Arthralgia, Abdominal pain, Contraindicated product administered, Liver injury, Memory impairment, Prescribed overdose, Delirium, Wound infection, Pain, Dizziness, Alopecia, Treatment noncompliance, Mobility decreased, Pericarditis, Glossodynia, Product use issue, Musculoskeletal stiffness, Live birth, Grip strength decreased, Treatment failure, Nausea, Fatigue, Rheumatoid arthritis, Pemphigus, Weight decreased, Drug intolerance, Duodenal ulcer perforation, Systemic lupus erythematosus, Sleep disorder, Psoriatic arthropathy, Dyspnoea, Psoriasis, Helicobacter infection, Hypertension, Condition aggravated, Rheumatic fever, Malaise, Dislocation of vertebra, Oedema, Hypersensitivity, Fibromyalgia, Blood cholesterol increased, Joint swelling, Blister, Abdominal discomfort, Amnesia, Swelling, Drug hypersensitivity, Disability, Diarrhoea, Swollen joint count increased, Synovitis, Infusion related reaction, Chest pain, General physical health deterioration, Intentional product use issue, Maternal exposure during pregnancy, Exposure during pregnancy, Anxiety, Wheezing, Rheumatoid factor positive, Infection, Decreased appetite, Rash, Adjustment disorder with depressed mood, Muscular weakness, Adverse event, Injury, Drug ineffective, Type 2 diabetes mellitus, Arthropathy, Gait disturbance, Headache, Anti-cyclic citrullinated peptide antibody positive, Hypoaesthesia, Discomfort, Joint range of motion decreased, Abdominal pain upper, Walking aid user, Hepatic enzyme increased, Adverse drug reaction, Therapeutic product effect decreased, Wound, Off label use, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, CELECOXIB, CELECOXIB, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, MAGNESIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SARILUMAB, APREPITANT, APREPITANT, APREPITANT, APREPITANT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, CALCIUM CARBONATE, ANTACID, SULFASALAZINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, RAMIPRIL, TOFACITINIB, TOFACITINIB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, CALCIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, APREMILAST, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, PREDNISONE, NAPROXEN, NAPROXEN SODIUM, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CERTOLIZUMAB PEGOL, CALCIUM GLUCONATE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, SECUKINUMAB, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LISINOPRIL, GOLIMUMAB, GOLIMUMAB, VITAMIN C, |
||||
| 390 | 25087323 |
BE |
||
Dysphonia, Colitis ulcerative, Upper respiratory tract infection, Fatigue, Weight decreased, Psoriasis, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 391 | 25088067 |
US |
54 | 1 |
Pancreatic disorder, Weight decreased, Migraine, |
||||
PANCRELIPASE, |
||||
| 392 | 25088397 |
US |
46 | 2 |
Weight decreased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 393 | 25088446 |
US |
||
Myxoma, Cardiac failure chronic, Dilated cardiomyopathy, Wheezing, Syncope, Pruritus, Dyspnoea, Nausea, Weight decreased, Hypotension, Chest discomfort, Fatigue, Pain, Tachycardia, Vomiting, Vertigo, Urticaria, Asthma, |
||||
| 394 | 25088452 |
US |
||
Nausea, Decreased appetite, Diarrhoea, Weight decreased, Fatigue, |
||||
SELINEXOR, AMLODIPINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, TELMISARTAN, HYDROCHLOROTHIAZIDE, |
||||
| 395 | 25088638 |
US |
||
Weight decreased, Cardiovascular disorder, |
||||
TIRZEPATIDE, |
||||
| 396 | 25088647 |
US |
47 | |
Product tampering, Nausea, Weight decreased, |
||||
TIRZEPATIDE, |
||||
| 397 | 25088705 |
GB |
||
Botulism, Malaise, Tongue coated, Dry eye, Eye irritation, Ear congestion, Food intolerance, Head discomfort, Anxiety, Dyspepsia, Amnesia, Photophobia, Hyperacusis, Arthritis, Hypoaesthesia, Ear discomfort, Ear pain, Bone pain, Weight decreased, Tinnitus, Alopecia, Myalgia, |
||||
| 398 | 25088734 |
US |
2 | |
Glaucoma, COVID-19, Diabetes mellitus, Decreased appetite, Weight decreased, Nausea, Vomiting, Diarrhoea, Gastrointestinal disorder, Infection, |
||||
NINTEDANIB, |
||||
| 399 | 25088764 |
CA |
63 | 2 |
Anaphylactic reaction, Anxiety, Aphthous ulcer, Asthenia, Asthma, Back pain, Bell^s palsy, COVID-19, Chills, Contusion, Cough, Decreased appetite, Discomfort, Dizziness, Dyspnoea, Eye haemorrhage, Eyelid ptosis, Fall, Fatigue, Feeling abnormal, Foreign body sensation in eyes, Headache, Hypertensive crisis, Hypoaesthesia, Illness, Inappropriate schedule of product administration, Injection site bruising, Injection site discomfort, Injection site pain, Injection site swelling, Injury, Lacrimation increased, Lethargy, Limb discomfort, Lipoma, Loss of consciousness, Mobility decreased, Malaise, Myalgia, Oropharyngeal pain, Oxygen saturation decreased, Pain, Paralysis, Paranasal sinus discomfort, Procedural pain, Productive cough, Pyrexia, Rhinorrhoea, Sinus congestion, Sputum discoloured, Symptom recurrence, Throat clearing, Tinnitus, Upper-airway cough syndrome, Urinary incontinence, Vaccination site pain, Visual impairment, Weight decreased, |
||||
RITUXIMAB, OMALIZUMAB, OMALIZUMAB, CEFUROXIME SODIUM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FUROSEMIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MOMETASONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SEMAGLUTIDE, MONTELUKAST SODIUM, |
||||
| 400 | 25088792 |
CA |
||
Asthenia, Drug ineffective, Decreased appetite, Diarrhoea, Fatigue, Haematochezia, Headache, Intestinal perforation, Pain, Pyrexia, Weight decreased, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, HYDROCORTISONE, RIFAMPIN, VEDOLIZUMAB, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28